• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Atypical Ebola virus disease in a rhesus macaque - IDSA

Mary Wilson

Well-known member
2023 Jul 21

DOI: 10.1093/infdis/jiad283

Andrea Marzi[SUP] 1[/SUP], Patrick W Hanley[SUP] 2[/SUP], Wakako Furuyama[SUP] 1[/SUP], Elaine Haddock[SUP] 1[/SUP], Craig A Martens[SUP] 3[/SUP], Dana P Scott[SUP] 2[/SUP], Heinz Feldmann[SUP] 1[/SUP]​

Abstract

Ebola virus (EBOV), strain Makona, infected more than 30,000 people from 2013-2016 in West Africa, among them many health care workers including foreign nationals. Most of the infected foreign nationals were evacuated and treated in their respective home countries resulting in detailed reports of the acute disease following EBOV infection as well as descriptions of symptoms now known as "Post-Ebola Syndrome" which occurred months after the infection. Symptoms associated with this syndrome include uveitis and neurological manifestations. In one of our EBOV-Makona nonhuman primate studies, one animal was euthanized on day 28 after EBOV-Makona infection having completely recovered from the acute disease and cleared EBOV from the blood. During convalescence, the animal developed neurological signs and acute respiratory distress requiring euthanasia. The organ tropism had changed with high virus titers in lungs, brain, eye, and reproductive organs but no virus in liver, spleen and adrenal glands, the typical target organs for acute EBOV infection. This in part reflects sequelae described for EBOV survivors in West Africa albeit developing quicker after recovery from acute disease.

https://watermark.silverchair.com/j..._9QeAnFbQ1MgS62-q8MTkvSUzYXSRbxNfpieCvenIJb0A
 
Back
Top